Project Number 5R21AT005510-03 Agency/Funding Organization NCCIH Funding Year 2014 View Full Project Details for PHASE 11-GRAPE SEED EXTRACT AS ANTI-OLIGOMERIZATION AGENT IN ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator GANDY, SAMUEL E. Principal Investigator First Name GANDY Principal Investigator Last Name SAMUEL E. Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-08-135: EXPLORATORY/DEVELOPMENTAL GRANT FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) STUDIES OF HUMANS (R21) FY Overall Cost $164,415 Funding Organization Agency/Funding Organization NCCIH Funding Organization Country United States Program Official WEBER, WENDY J Related Resources Clinical Trial Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)
